Summary: An enzyme-linked immunosorbent assay to detect antinuclear antibodies in the sera of patients with autoimmune diseases is described. Goat liver nuclei were immobilized on polystyrene plates and antinuclear antibodies were used to standardize the assay. The effects of variables, such as the nuclei concentration, conditions of nuclei storage, and the length of the incubation period were investigated on the assay. Prototype sera with known antibody specificity were used to evaluate the assay. The method described is highly sensitive, autoantibodies being detectable at serum dilutions of 1 : 1000 or higher. According to the intra-and inter-assay coefficient of variation, the results were highly reproducible.
Introduction
Enzyme immunoassays have been successfully employed for the quantitation of human autoantibodies of defined specificities using purified antigen adsorbed on a solid matrix (reviewed in I.e. (1)). Some variations of the procedure include the use of nylon beads as the solid support (2-4) instead of a conventional polystyrene surface, and the use of a fluorogenic substrate (5) for the evaluation of enzyme activity.
In the present work, an enzyme-linked immunosorbent assay (ELISA) was evaluated as an alternative to the fluorescent antinuclear antibody (FANA) as-*) List of antigens nDNA = native DNA UlsnRNP = ... small nuclear ribonucleoprotein Sm = an antigen, named from the initials of the patient who showed corresponding antibodies; a nuclear glycoprotein ANA = antinuclear antibodies RNP = Ribonucleoprotein SS-B/La = an antigen B, characterized by sera of certain patients with Sjögren syndrome (SS) SS-A/Ro = an antigen A, characterized by sera of certain patients with Sjögren syndrome (SS) = an antigen of M r = 70.000, identified by sera of certain patients suffering from sclefoderma (Sc !) say. Purified nuclei from goat liver were immobilized on polystyrene plates to detect antinuclear antibodies (ANA) 1 ) in patients with systemic lupus erythematosus. The effects of the nuclei concentration, storage of nuclei below 0 °C, and the length of the incubation period was investigated on the assay. Sera from patients with systemic lupus erythematosus gave positive tests. In addition to the sera containing antinuclear antibodies, prototype sera with antibody specificity 1 ) to nDNA, UlsnRNP, Sm, nucleosomes, centromere, ANA (RNP, SS-B/La, SS-A/Ro) and Scl-70 autoantigens were used in this study. Positive results were obtained with these samples. Sera from normal individuals were used as controls.
Materials and Methods

Materials
Polystyrene plates from Dynatech, USA, were used as the solid support for antigen binding. Anti-human IgG alkaline phosphatase conjugate, poly D-lysine, poly Z)-glutamate, calf thymus DNA and bovine serum albumin were from the Sigma Chemical Company, USA. /?-Nitrophenyl phosphate was obtained from the C. S. I. R. Centre for Biochemicals, New Delhi. Nonidet P-40 was from BDH Chemicals, England. A Dynatech ELISA microplate reader MR 600 was used for absorption measurements. ra and Ali: Assay of antinuclear antibodies by BLISA Sera specimens Normal human sera and sera from patients with systemic lupus erythematosus who met the preliminary criteria of the American Rheumatism Association for this disease (6), were obtained as described elsewhere (7) . All sera were stored at -20°C until examined and were decomplemented before use by heating at 56 °C for 30 min. Prototype sera were obtained from Centers for Disease Control, Atlanta, Georgia, USA, and were rehydrated by adding 0.5 ml of distilled water.
Preparation of antigen
Goat liver nuclei were isolated as described earlier (8) . The isolated nuclei were suspended in 0.25 mol/1 sucrose, 3 mmol/1 calcium chloride solution (8.0 ml) and carefully layered over 3.0 ml of Ficoll solution (1.0 kg/1 in the sucrose/calcium chloride solution). The suspension was centrifuged at 700 g for 10 min and the purified nuclei were collected at the bottom of the centrifuge tube. The purified nuclei were inspected under the light microscope using haematoxylin stain.
Enzyme-linked immunosorbent assay
The technique of Aotsuka et al. (9) was used for the detection and quantitation of anti-DNA antibodies. Direct binding of antinuclear antibodies to nuclei as antigen (ANA-ELISA) was determined essentially as previously described (5) . A polystyrene microtitre plate was incubated with 50 μΐ nuclear suspension (1000 nuclei/50 μΐ in carbonate-bicarbonate buffer, pH 9.6) for 2 h at room temperature and overnight at 4 °C. The plate was washed three times with saline-Tween 20 and unoccupied sites were blocked with 10 g/1 bovine serum albumin in saline-Tween 20 for 6 h. Decomplemented sera, dilution in saline-Tween 20, were adsorbed for 2 h and overnight at 4°C. The unbound material was washed four times with saline-Tween 20 and antihuman alkaline phosphatase conjugate (1:1500 dilution in saline-Tween 20) was added. After 2 h at room temperature, the plate was washed three times with saline-Tween 20. The substrate (p-nitrophenyl phosphate, 5 mmol/1 in carbonate buffer containing 2 mmol/1 magnesium chloride, pH 9.5) was added and absorbance was recorded at 410 nm after appropriate colour development. In each step 100 μΐ of solution was added and each sample was run in duplicate. The control wells were treated similarly but were devoid of antigen. Sera were tested at a dilution of 1:1000 unless mentioned otherwise.
Data analysis
Values obtained with 25 normal healthy individuals were used for determining the cut off level for distinguishing antibodypositive and antibody-negative samples. A value of twice the standard deviation above the mean, i. e. 0.20, was chosen as a cut off value. A test sample was positive if the mean absorbance of duplicate measurements was greater than 0.20 and negative if the mean absorbance was lower.
Accuracy and precision studies
The reprpducibility of the assay procedure was ascertained by determining the intra-and inter-assay coefficient of variation for three normal and seven antinuclear antibody positive systemic lupus erythematosus sera. These samples were tested seven times in one day in order to determine the intra-assay coefficient of variation, whereas testing of the same samples for seven consecutive days gave the inter-assay coefficient of variation.
Results
Nuclei from goat liver were used as antigen for the ELISA. The isolated nuclei were 90% pure, based on staining with haematoxylin, epd the total particle count. Mitochondria and lysosomal particles accounted for less than 0.1% of the total particles in the nuclear preparations. Small amorphous components were present in amounts ranging from 1 -8%. A series of preliminary experiments were carried out to determine the effect of certain variables on assay procedure.
Storage of nuclei
When the ELISA was carried out with nuclei that had been stored up to two weeks at -20 °C, almost no change in antibody binding was observed. However, a considerable decrease in binding was observed when the nuclei had been stored for longer periods ( fig. 1 ). It is suggested that isolated nuclei stored at -20 °C can be used for the ELISA for about two weeks without appreciable loss in antigenicity. 
Fixing of nuclei
The nuclei become tightly adsorbed to the polystyrene surface. Repeated washing of adsorbed nuclei with saline-Tween 20 had almost no effect on the nuclei count. Binding of nuclei to the polystyrene surface was found to be 75-80% of added nuclei ( fig. 2) .
Concentration of nuclei
The ELISA was performed witihi increasing concentrations of nuclei at three different dilutions of two antinuclear antibody-positive systemic lupus erythe- matosus sera. Antibody binding reached a maximum at 1000 nuclei bound per well. Further increases in the concentration of bound nuclei were accompanied by a marked decrease in antibody binding ( fig. 3 ). The antibody binding profile was similar with different dilutions of each serum. In view of the sudden drop in antibody binding following any attempt to increase the coating above 1000 nuclei/well, the experiment was repeated three times to ascertain data reproducibility. Each time an almost identical profile was obtained. 
ANA-ELISA
Normal human sera, and sera of systemic hipus erythematosus patients with different level of antibody activity, were tested for antinuclear antibodies with the ELISA at various dilutions of serum. Ten out of twelve (83%) systemic lupus erythematosus patients were positive for antibodies to antinuclear antibodies when purified nuclei were used as antigen. In figure  4 , titrations of three sera from systemic lupus erythematosus patients are compared with a normal human serum. The ELISA was also carried out with samples of systemic lupus erythematosus sera, using nDNA as antigen. Figure 5 shows the results obtained with various antibody-positive systemic lupus erythematosus sera.
3.3 3.6 3.9 -log serum dilution The reference sera from the Centers for Disease Control, Atlanta, Georgia, USA, with antibody specificity for nDNA, RNP, Sm, nucleolus, centromere, ANA (RNP, SS-B/La, SS-A/Ro) and Scl-70 were analysed for their antibody content against nuclei, using the EL1SA. All the prototype sera demonstrated strong antibody binding. The characteristic of reference sera as provided by the supplier and the titre obtained by ANA-ELISA are shown in table 1. The end point titre for individual sera is expressed as the mean of duplicate samples. Normal human sera and sera from patients with non-autoimmune diseases (25 serum samples) were negative for antinuclear antibodies. Systemic lupus 1.
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Mean absorbance + The values in parentheses represent coefficient of variation. Serum dilution was 1 :1000.
Ara and Ali: Assay of antinuclear antibodies by ELISA Precision Table 2 shows the intra-and inter-assay coefficients of variation for the measurement of antinuclear antibodies in seven positive systepiic lupus erythematosus sera. A high degree of reproducibility of the assay procedure is evident from the data.
Discussion
The fluorescent antinuclear antibody (FANA) technique of Coons & Kaplan (10) has become important as a widely used method for detecting antinuclear antibodies in the sera of patients with autoimmune diseases. Despite being the established method for detecting and quantifying antibodies, FANA has certain limitations, e. g. the use of fluorescent microscopy, wide variation in reagent quality, and the lack of a standard substrate for detecting a variety of autoantibodies (11, 12) .
The studies reported here indicate that the identification of antibodies to nuclear antigens can be conveniently carried out with the ELISA, employing purified nuclei as the source of antigen.
In preliminary studies we observed a nearly linear relationship between antibody binding and nuclei concentration up to 1000 nuclei/well; further increases in the concentration of bound nuclei were accompanied by a marked decrease in antibody binding. Re-testing of sera at different dilutions yielded similar binding profile. It is possible that at higher concentrations the nuclei were adsorbed in layers which were easily lost during washing.
Sera of 12 systemic lupus erythematosus patients were examined with the ELISA, using nDNA and purified nuclei as the antigens. With two exceptions, a high titre of antibody binding against each of these two antigens was observed. One patient displayed high titre antibodies to nuclei, but showed a negative reaction with nDNA. This difference in antigen recognition could be due to the presence of antibodies in systemic lupus erythematosus sera against a nuclear antigen different from DNA. In contrast, another patient, although positive for anti-DNA antibody activity, showed a reaction with nuclei. The heterogeneity of systemic lupus erythematosus sera is well documented, and the antibody binding could be due to recognition of single stranded regions in nDNA which are practically impossible to remove totally. With this technique, antibodies were readily detected, with maximal reactivity at a» serum dilution of 1 :1000; this is a significantly higher titre than the 1 :100 observed for nDNA binding.
Examination of various reference sera with known antibody specificities clearly demonstrated the sensitivity of the technique. The most prominent of our finding was a high reactivity towards RNP, Sm, nDNA, nucleolar and Scl-70 sera, with end point litres higher than in the FANA assay (tab. 1).
In summary, the method described for detection of antinuclear antibodies is a reliable alternative to FANA. It is more convenient to perform, and it produces quantitative, reproducible data, with a high degree of accuracy that is acceptable for most serological assays involving serial dilution of serum.
